Comparative Study of the Influence of Proteasome Inhibitor MG132 and Ganciclovir on the Cytomegalovirus-Specific CD8+T-Cell Immune Response-Reference-Cited by-同舟云学术

Comparative Study of the Influence of Proteasome Inhibitor MG132 and Ganciclovir on the Cytomegalovirus-Specific CD8+T-Cell Immune Response

Published:2011-12 Issue:6 Volume:24 Page:455-461
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Wang Yanjun¹²,Sun Bin³,Volk Hans-Dieter¹,Proesch Susanna⁴,Kern Florian⁵

Affiliation:

1. Institut für Medizinische Immunologie der Charité, Abteilung Klinische Immunologie, Humboldt-Universität zu Berlin (Charité), Campus Charité Mitte, Berlin, Germany.

2. Beijing Institute of Liver Diseases, Capital Medical University, Beijing, China.

3. Intervention Therapy Center of Liver Diseases, Beijing You An Hospital, Capital Medical University, Beijing, China.

4. Institut für Virologie der Charité, Campus Mitte, Berlin, Germany.

5. BSMS, University of Sussex, Falmer, Brighton, U.K.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2011.0038

Reference30 articles.

1. The immunogenicity of human and murine cytomegaloviruses

2. T-Cell Immunity to Subclinical Cytomegalovirus Infection Reduces Cardiac Allograft Disease

3. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation

4. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

5. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the proteasome system: A novel concept of proteasome inhibition and regulation;Pharmacology & Therapeutics;2020-07

2. Ub to no good: How cytomegaloviruses exploit the ubiquitin proteasome system;Virus Research;2020-05

3. MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexia;Journal of Cancer Research and Clinical Oncology;2013-03-28